期刊
NUCLEIC ACIDS RESEARCH
卷 51, 期 10, 页码 4959-4981出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkad246
关键词
-
AP sites are DNA lesions that cause cytotoxicity, replication-blocks, and mutations. HMCES interacts with AP sites in single stranded DNA to form stable thiazolidine protein-DNA crosslinks and protect cells. The crosslinked HMCES is degraded by proteasome, and APE1 can incise the protease-digested HMCES adducts. These findings provide insights into the damage tolerance and repair pathways for HMCES-DNA crosslinks in human cells.
Apurinic/apyrimidinic (AP) sites are DNA lesions created under normal growth conditions that result in cytotoxicity, replication-blocks, and mutations. AP sites are susceptible to beta-elimination and are liable to be converted to DNA strand breaks. HMCES (5-hydroxymethylcytosine binding, ES cell specific) protein interacts with AP sites in single stranded (ss) DNA exposed at DNA replication forks to generate a stable thiazolidine protein-DNA crosslink and protect cells against AP site toxicity. The crosslinked HMCES is resolved by proteasome-mediated degradation; however, it is unclear how HMCES-crosslinked ssDNA and the resulting proteasome-degraded HMCES adducts are processed and repaired. Here, we describe methods for the preparation of thiazolidine adduct-containing oligonucleotides and determination of their structure. We demonstrate that the HMCES-crosslink is a strong replication blocking adduct and that protease-digested HMCES adducts block DNA replication to a similar extent as AP sites. Moreover, we show that the human AP endonuclease APE1 incises DNA 5 ' to the protease-digested HMCES adduct. Interestingly, while HMCES-ssDNA crosslinks are stable, the crosslink is reversed upon the formation of dsDNA, possibly due to a catalytic reverse reaction. Our results shed new light on damage tolerance and repair pathways for HMCES-DNA crosslinks in human cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据